A groundbreaking new treatment for multiple sclerosis is set to begin clinical trials in Greece by mid-2024, offering hope to ...

NEW YORK, Nov. 21, 2024 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced it ranked number one on the Deloitte Technology Fast 500™, a ranking of the 500 fastest-growing ...

A pioneering clinical trial in Cambridge is bringing renewed hope to those living with multiple sclerosis (MS), a condition where the immune system mistakenly attacks the protective covering of ...

Claimable, a pioneering healthcare technology company, today announced the launch of its free AI-powered appeals platform designed to help children with PANS/PANDAS overcome insurance denials and ...

Dapirolizumab pegol was better than a placebo at controlling disease activity in systemic lupus erythematosus patients in a Phase 3 trial.

The partner of a Cornwall man who died after complaining of severe abdominal pain called 999 five times before an ambulance ...

According to the University of Texas at Dallas, FAS often develops following central nervous system damage, such as stroke, brain injury, multiple sclerosis, or other conditions that affect the brain ...

A new study shows stimulating the vagus nerve in mice with colitis reduced stress-driven symptoms of inflammatory bowel disease by regulating SUMOylation, an immune response that triggers gut ...

A new neuroimaging marker of cerebral small vessel disease is related to general cognition and may serve to identify persons ...

Treatment with metformin was associated with improved salivary gland function and reduced ocular symptoms among patients with ...

Eye diseases like glaucoma, cataracts, and conjunctivitis are some of the more common types. Find eye disease awareness and ...

Objective Systemic lupus erythematosus (SLE) is an autoimmune disease characterised by a loss of immune tolerance, affecting ...